{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:10:17Z","timestamp":1740157817889,"version":"3.37.3"},"reference-count":40,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.7765","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T09:13:58Z","timestamp":1515575638000},"source":"Crossref","is-referenced-by-count":3,"title":["Utility of Survivin, BAP1, and Ki\u201167 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia"],"prefix":"10.3892","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2474-5969","authenticated-orcid":false,"given":"Kei","family":"Kushitani","sequence":"first","affiliation":[{"name":"Department of Pathology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishwa","family":"Amatya","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany","family":"Mawas","sequence":"additional","affiliation":[{"name":"Department of Pathology and Clinical Pathology, Faculty of Veterinary Medicine, South Valley University, Qena 83523, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Research Center for Radiation Casualty Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Research Center for Radiation Casualty Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouki","family":"Inai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Okayama Rosai Hospital, Okayama 702\u20118055, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Takeshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"key20200714002520_b1-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"key20200714002520_b2-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/01913120252959227","article-title":"Malignant mesothelioma and occupational exposure to asbestos: A clinicopathological correlation of 1445 cases","volume":"26","author":"Roggli","year":"2002","journal-title":"Ultrastruct Pathol"},{"key":"key20200714002520_b3-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Delgermaa","year":"2011","journal-title":"Bull World Health Organ"},{"key":"key20200714002520_b4-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajim.20246","article-title":"Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model","volume":"49","author":"Murayama","year":"2006","journal-title":"Am J Ind Med"},{"key":"key20200714002520_b5-ol-0-0-7765","first-page":"153","volume-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart","author":"Churg","year":"2015"},{"key":"key20200714002520_b6-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"key20200714002520_b7-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2012.05.014","article-title":"Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: A review and update","volume":"44","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Hum Pathol"},{"key":"key20200714002520_b8-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/his.13073","article-title":"Utility and pitfall of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma","volume":"70","author":"Kushitani","year":"2017","journal-title":"Histopathology"},{"key":"key20200714002520_b9-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1309\/AJCP5KNL7QTELLYI","article-title":"Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells","volume":"141","author":"Minato","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"key20200714002520_b10-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/pin.12453","article-title":"BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests","volume":"66","author":"Hida","year":"2016","journal-title":"Pathol Int"},{"key":"key20200714002520_b11-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/PAS.0000000000000616","article-title":"Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"key20200714002520_b12-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","article-title":"BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma","volume":"46","author":"McGregor","year":"2015","journal-title":"Hum Pathol"},{"key":"key20200714002520_b13-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod Pathol"},{"key":"key20200714002520_b14-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1159\/000350262","article-title":"Differential diagnosis of reactive mesothelial cells and malignant mesothelioma cells using the cell proliferation markers minichromosome maintenance protein 7, geminin, topoisomerase II alpha and Ki-67","volume":"57","author":"Kimura","year":"2013","journal-title":"Acta Cytol"},{"key":"key20200714002520_b15-ol-0-0-7765","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/dc.21190","article-title":"Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIalpha and Ki-67) in cavital fluid cytology: Can we differentiate reactive mesothelial cells from malignant cells?","volume":"38","author":"Kimura","year":"2010","journal-title":"Diagn Cytopathol"},{"key":"key20200714002520_b16-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/cncy.20087","article-title":"The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions","volume":"118","author":"Hasteh","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"key20200714002520_b17-ol-0-0-7765","doi-asserted-by":"crossref","first-page":"694","DOI":"10.5858\/2008-132-694-TDVOKA","article-title":"The diagnostic value of Ki-67 and repp86 in distinguishing between benign and malignant mesothelial proliferations","volume":"132","author":"Taheri","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"key20200714002520_b18-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"318","DOI":"10.5858\/arpa.2015-0240-SA","article-title":"New markers for separating benign from malignant mesothelial proliferations: Are we there yet?","volume":"140","author":"Churg","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"key20200714002520_b19-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/dc.23490","article-title":"Cytologic differential diagnosis of malignant mesothelioma and reactive mesothelial cells with fish analysis of p16","volume":"44","author":"Hiroshima","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"key20200714002520_b20-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/dc.23491","article-title":"BAP1 immunostain and CDKN2A (p16) FISH analysis: Clinical applicability for the diagnosis of malignant mesothelioma in effusions","volume":"44","author":"Walts","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"key20200714002520_b21-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000442092","article-title":"Use of anti-noxa antibody for differential diagnosis between epithelioid mesothelioma and reactive mesothelial hyperplasia","volume":"83","author":"Kushitani","year":"2016","journal-title":"Pathobiology"},{"key":"key20200714002520_b22-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization Classification of Lung Tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"key20200714002520_b23-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"key20200714002520_b24-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12935-016-0326-1","article-title":"Survivin: A unique target for tumor therapy","volume":"16","author":"Garg","year":"2016","journal-title":"Cancer Cell Int"},{"key":"key20200714002520_b25-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.molonc.2016.06.005","article-title":"Low merlin expression and high survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma","volume":"10","author":"Meerang","year":"2016","journal-title":"Mol Oncol"},{"key":"key20200714002520_b26-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00428-013-1373-9","article-title":"Is survivin expression prognostic or predictive in malignant pleural mesothelioma?","volume":"462","author":"Hmeljak","year":"2013","journal-title":"Virchows Arch"},{"key":"key20200714002520_b27-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cca.2014.12.029","article-title":"The diagnostic value of survivin in malignant pleural effusion: A meta-analysis","volume":"441","author":"Chen","year":"2015","journal-title":"Clin Chim Acta"},{"key":"key20200714002520_b28-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/ijc.28048","article-title":"Fowlpox-based survivin vaccination for malignant mesothelioma therapy","volume":"133","author":"Bertino","year":"2013","journal-title":"Int J Cancer"},{"key":"key20200714002520_b29-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"13119","DOI":"10.18632\/oncotarget.3761","article-title":"Anti-tumor activity of selective inhibitors of XPO1\/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: The role of survivin","volume":"6","author":"De Cesare","year":"2015","journal-title":"Oncotarget"},{"key":"key20200714002520_b30-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"316739","DOI":"10.1155\/2015\/316739","article-title":"Serum survivin levels and outcome of chemotherapy in patients with malignant mesothelioma","volume":"2015","author":"Gori\u010dar","year":"2015","journal-title":"Dis Markers"},{"key":"key20200714002520_b31-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/PAT.0b013e32835d0efb","article-title":"Tumours associated with BAP1 mutations","volume":"45","author":"Murali","year":"2013","journal-title":"Pathology"},{"key":"key20200714002520_b32-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature08966","article-title":"Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB","volume":"465","author":"Scheuermann","year":"2010","journal-title":"Nature"},{"key":"key20200714002520_b33-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"key20200714002520_b34-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"key20200714002520_b35-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci"},{"key":"key20200714002520_b36-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/his.13123","article-title":"Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma","volume":"70","author":"Shinozaki-Ushiku","year":"2017","journal-title":"Histopathology"},{"key":"key20200714002520_b37-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: From the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"key20200714002520_b38-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-2559.1990.tb00788.x","article-title":"Monoclonal antibody Ki-67: Its use in histopathology","volume":"17","author":"Brown","year":"1990","journal-title":"Histopathology"},{"key":"key20200714002520_b39-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrc968","article-title":"Validating survivin as a cancer therapeutic target","volume":"3","author":"Altieri","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20200714002520_b40-ol-0-0-7765","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.bbrc.2006.09.143","article-title":"Nuclear interaction of Smac\/DIABLO with survivin at G2\/M arrest prompts docetaxel-induced apoptosis in DU145 prostate cancer cells","volume":"350","author":"Kim","year":"2006","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T11:36:27Z","timestamp":1719747387000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.7765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":40,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.7765","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"type":"print","value":"1792-1074"},{"type":"electronic","value":"1792-1082"}],"subject":[],"published":{"date-parts":[[2018,1,10]]}}}